kv-web

Electrocardiograph

With the globally recognised Glasgow 12-lead analysis and easy-to-use technology, Mindray’s BeneHeart R3/R12 electrocardiographs can meet a range of different clinical demands.

Insights
Every patient is different and our ECG machines use world-class standards to enhance reading accuracy and diagnostics. The 2009 AHA/ACCF/HRS recommendations have new ST elevation myocardial infarction (STEMI) criteria that now depend on both age and gender. In addition, the patient’s race, medication history, etc. will also affect the results of an ECG interpretation. The physiological structure of newborns and infants is slightly different from that of adults - the right ventricle is larger and thicker than the left ventricle. Therefore, a special algorithm for paediatric use is required to provide more reliable and accurate diagnoses.
Challenges1
Glasgow 12-lead analysis
The industry-recognised Glasgow 12-lead analysis supports accurate diagnosis in adults and children from birth upwards around the world. Continuous development of the Glasgow algorithm for over 40 years delivers one of the world's best methods of ECG analysis.
Challenges2
Digital pacemaker detection
Digital pacemaker detection provides a reliable report of the atrial, ventricular and A-V sequential pacing mode without selecting pacemaker detection sensitivity.
product-1-web
BeneHeart R12

The BeneHeart R12 is a twelve-channel ECG device with user-friendly design which features reliable internal analysis using the Glasgow algorithm. Comprehensive functionality comes in a robust and portable device to deliver rapid and accurate ECG’s - ideal for general wards or emergency departments.

 

Learn more >

Electrocardiograph Products
BeneHeart Series
BeneHeart R12
BeneHeart R12
12 channel electrocardiograph
BeneHeart R3
BeneHeart R3